Pulse Biosciences Inc.
PLSE | NASDAQ
$52.21
-$1.66 (-3.08%)
Sep 21, 2026, 11:07 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 350K | n/a | n/a | 700K | 1.42M | n/a |
Cost of Revenue | 1.61M | n/a | 1.21M | 11.94M | 1.97M | 1.1M |
Gross Profit | -1.26M | n/a | -1.21M | -11.24M | -550K | -1.1M |
Operating Income | -76.94M | -56.26M | -43.57M | -58.06M | -63.01M | -49.97M |
Interest Income | 4.21M | 2.67M | 2.46M | n/a | n/a | 114K |
Pretax Income | -72.78M | -53.59M | -42.21M | -58.51M | -63.66M | -49.85M |
Net Income | -72.78M | -53.59M | -42.21M | -58.51M | -63.66M | -49.74M |
Selling & General & Admin | 32.03M | 23.92M | 15.78M | 25.97M | 33.82M | 22.86M |
Research & Development | 44.72M | 32.34M | 27.8M | 20.84M | 28.64M | 26.44M |
Other Expenses | -1.07M | n/a | -1.21M | n/a | n/a | -430K |
Operating Expenses | 75.68M | 56.26M | 42.37M | 46.81M | 62.46M | 48.87M |
Interest Expense | n/a | n/a | 1.1M | 448K | 646K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 12.02M | 14.75M | n/a |
Cost & Expenses | 77.29M | 56.26M | 43.57M | 58.76M | 64.43M | 49.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 67.4M | 58.4M | 48.04M | 33.94M | 27.96M | 23.25M |
Shares Outstanding (Diluted) | 67.4M | 58.4M | 48.04M | 33.94M | 27.96M | 23.25M |
EPS (Basic) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 |
EPS (Diluted) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 |
EBITDA | -71.71M | -52.41M | -39.9M | -57.15M | -62.51M | -48.87M |
EBIT | -72.78M | -53.59M | -41.11M | -58.51M | -63.66M | -49.85M |
Depreciation & Amortization | 1.07M | 1.18M | 1.21M | 1.36M | 1.15M | 1.1M |
Add to Watchlist
Select watchlists to add or remove PLSE